Clinical and Translational Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.7 | Q3 | 44.7% | 0.833 | Q2 | 78.6% |
| 2024 | 2.5 | Q3 | 42.6% | 0.903 | Q2 | 81.5% |
| 2023 | 2.8 | Q2 | 48.0% | 0.837 | Q2 | 81.1% |
| 2022 | 3.4 | Q3 | 51.2% | 0.831 | Q2 | 81.6% |
| 2021 | 3.3 | Q3 | 46.6% | 0.764 | Q2 | 79.9% |
| 2020 | — | — | 0.902 | Q2 | 82.8% | |
| 2019 | — | — | 0.833 | Q2 | 81.3% | |
| 2018 | — | — | 0.883 | Q1 | 81.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1699-3055
ISSN
1699-048X
region
Western Europe
coverage
2000-2026